FLSM
PEPG icon

Frazier Life Sciences Management’s PepGen PEPG Stock Holding History

Frazier Life Sciences Management’s Portfolio PEPG Stock Details PEPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-702,694
Closed -$6.01M – 54
2024
Q3 		$6.01M Sell
702,694
-800,094
-53% -$9.47M 0.24% 47
2024
Q2 		$24M Hold
1,502,788
– – 1.12% 24
2024
Q1 		$22.1M Buy
+1,502,788
New +$17.7M 0.93% 30

Other funds holding PEPG

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Frazier Life Sciences Management's PEPG Position: Q4 2024 in Review

Frazier Life Sciences Management sold out of PepGen (PEPG) in Q4 2024, closing a stake of 702,694 shares — an estimated $6.01M sold.

Frazier Life Sciences Management first reported a position in PEPG in Q1 2024 and held it in 3 quarters. The position peaked at $24M in Q2 2024. 61 funds tracked by Wall St. Rank hold PEPG as of Q4 2024.

  • Frazier Life Sciences Management reported no remaining PepGen position as of Q4 2024 after selling out during the quarter.
  • Frazier Life Sciences Management sold 702,694 PepGen shares in Q4 2024, an estimated $6.01M.
  • Frazier Life Sciences Management first reported a position in PepGen in Q1 2024 and held it in 3 quarters.
  • Frazier Life Sciences Management's PepGen position peaked at $24M in Q2 2024.
  • 61 funds tracked by Wall St. Rank held PepGen as of Q4 2024.

Based on Frazier Life Sciences Management's 13F filing for Q4 2024, filed 18 Feb 2025.